Delivery Order SPE2DB24D1104-SPE2DB25FXWH0
Award Date
1/8/25
Potential Completion Date
1/9/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The $11,777.66 delivery order contract is a Firm Fixed Price arrangement with a completion date of May 21, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a wide range of medical commodities including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,583.28 firm-fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a prescription medication, to the agency. The contract has an ultimate completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGE ML pharmaceutical products. The firm fixed price delivery order has a potential value of $3,562.48 and a completion date of February 13, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of COPAXONE 40 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order has a potential value of $2,269.52 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not designated as a...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB25FKXZ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.47 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication, with a completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FJF56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,281.46, is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of July 17, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award, valued at $1,908.00, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of May 6, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award, valued at $2,474.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The period of performance runs through September 27, 2024. The contract is not set aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, identified as SPE2DB22D1200|SPE2DB25FM9BJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,583.28, is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a multiple sclerosis medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 20, 2024. Amerisourcebergen Drug Corp, the prime...